News

CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.

eHealth says surging 2027 health costs are pushing smaller employers toward ICHRAs, potentially expanding individual coverage demand.

Based on the average brokerage recommendation (ABR), UnitedHealth (UNH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.

CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...

UnitedHealth is staging a turnaround after raising full-year adjusted EPS guidance. The firm also pays an annualized dividend of $9.28 with a yield above 2.4%.

A 15-year scorecard just revealed how badly active dividend fund managers fared against a passive benchmark, and the results raise a pointed question about whether the most popular dividend ETF belongs in your portfolio right now.

UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.

Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable dividends.

Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Following a strong rebound from the first-quarter decline, the S&P 500 gained 15.2% as accelerating capital spending toward artificial intelligence infrastructure drove significant gains across technology hardware companies. Semiconductor and data-center-related businesses benefited from supply constraints […]

Walmart, UnitedHealth and Wells Fargo highlight resilient growth, while XMax and Interlink pursue expansion despite execution challenges.

UnitedHealth, Dell and Goldman Sachs headline a week of rate decisions, rising commodity inflation and global political uncertainty.

CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.

UnitedHealth Group Incorporated (NYSE:UNH) has sold an interest in some of its Optum Health operations in Florida to private-equity firm TPG, specifically involving its WellMed clinics that focus heavily on older patients. UnitedHealth’s CFO said the move is not about raising cash, but about bringing in a partner that can provide local operating expertise and […]

The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.

Walmart's omnichannel strength, UnitedHealth's raised 2026 EPS outlook and Wells Fargo's asset-cap removal highlight today's reports.

Optum Health hit a wall due to rising costs and restrictive Medicare Advantage payments.

UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.

THC's shares are gaining on higher-acuity demand, strong commercial revenues and USPI's continued expansion.

UnitedHealth (UNH) has been facing investor questions surrounding the upcoming release of Medicare A

CAT, TSM, UNH, TER and ZBRA are five wide moat stocks that stand out for durable advantages, strong growth prospects and favorable demand across key markets.

UnitedHealth Group Inc (NYSE:UNH) recently announced a total dividend of $2.32 per share, with the ex-dividend date set for 2026-09-14. This amount consists of $2.32 per share in cash dividends, payable on 2026-09-22. Investors should note that the ex-dividend date of 2026-09-14 means shareholders must own the stock before that date to qualify for the payment.

A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash flow to keep doing it.

UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

In the latest trading session, UnitedHealth Group (UNH) closed at $379.09, marking a -2.37% move from the previous day.

CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.

Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.